Schizophrenia is a leading cause of global disability. Current pharmacotherapy for the
disease predominantly uses one mechanism—dopamine D2 receptor blockade—but often …

The neurodevelopmental hypothesis of schizophrenia has long suggested that the cardinal
psychotic symptoms that have traditionally defined the disorder, and which most commonly …

Background: Schizophrenia is a serious psychiatric disorder that significantly affects the
quality of life of patients. The objective of this study is to discover a novel antipsychotic …

Recent studies have highlighted the potential involvement of reactive oxygen species (ROS)
and microglia, a major source of ROS, in the pathophysiology of schizophrenia. In our study …

A focus should be made by clinicians to personalize treatment plans for each patient who
has the possibility of being diagnosed with a primary psychosis and the plan should be to …

A substantial portion of schizophrenia spectrum disorder (SSD) patients exhibit resistance to
antipsychotic treatments, emphasizing the need for reliable treatment response biomarkers …

Schizophrenia is a complex psychiatric disorder characterized by a wide range of symptoms
including hallucinations, delusions, disorganized speech, and cognitive impairments. It is …

People with schizophrenia often experience considerable difficulties in daily life because of
a wide constellation of symptoms associated with the condition. This article examines the …

La esquizofrenia es una enfermedad mental crónica caracterizada por tres conjuntos de
síntomas: positivos, negativos y cognitivos. Aunque los primeros han logrado abordarse con …

A inclusão da família e do doente no projeto terapêutico para a recuperação da pessoa com
Doença Mental Grave assume grande importância, desde o internamento até aos cuidados …